Sunitinib Malate Capsules 25 mg is a widely prescribed targeted therapy used in the treatment of various types of cancer, including renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors. Known for its effectiveness in slowing tumor growth, Sunitinib works by inhibiting multiple receptor tyrosine kinases responsible for tumor proliferation and angiogenesis.
Cordium Pharmaceuticals Pvt Ltd, a trusted global exporter based in India, ensures the reliable supply of high-quality Sunitinib Malate Capsules 25 mg with fast and secure delivery to major international markets including the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Usage:
Sunitinib Malate Capsules are used under medical supervision for treating advanced kidney cancer, gastrointestinal stromal tumors resistant to other treatments, and certain pancreatic tumors. It helps in blocking the growth and spread of cancer cells.
Dosage:
The typical dosage of Sunitinib Malate Capsules 25 mg depends on the patient’s condition and doctor’s prescription. It is usually taken orally once daily, with or without food, in cycles (e.g., 4 weeks on treatment followed by 2 weeks off). Always follow your healthcare provider’s instructions strictly.
Side Effects:
Common side effects may include fatigue, diarrhea, nausea, loss of appetite, high blood pressure, and skin discoloration. Serious side effects can include liver problems, heart issues, and bleeding complications. Immediate medical attention is required if severe reactions occur.
Cordium Pharmaceuticals Pvt Ltd ensures stringent quality standards, competitive pricing, and efficient global logistics to meet urgent medical needs. With a commitment to excellence and timely delivery, the company has become a preferred partner for international buyers.
For bulk orders, inquiries, and quick delivery:
📞 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
